Literature DB >> 31307981

Synergistic Combinations and Repurposed Antibiotics Active against the Pandrug-Resistant Klebsiella pneumoniae Nevada Strain.

Thea Brennan-Krohn1,2,3, James E Kirby4,3.   

Abstract

Entities:  

Keywords:  NDM-1; antimicrobial resistance; apramycin; carbapenem-resistant Enterobacteriaceaezzm321990; colistin; multidrug resistance; repurposed; spectinomycin; synergy

Mesh：

Substances：

Year:  2019        PMID： 31307981      PMCID： PMC6709503          DOI： 10.1128/AAC.01374-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  13 in total

1.  Synergistic Activity of Colistin-Containing Combinations against Colistin-Resistant Enterobacteriaceae.

Authors:  Thea Brennan-Krohn; Alejandro Pironti; James E Kirby
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

2.  Unexpected in vivo activity of ceftazidime alone and in combination with avibactam against New Delhi metallo-β-lactamase-producing Enterobacteriaceae in a murine thigh infection model.

Authors:  Shawn H MacVane; Jared L Crandon; Wright W Nichols; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2014-09-15       Impact factor: 5.191

3.  Invitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.

Authors:  Anthony D Kang; Kenneth P Smith; George M Eliopoulos; Anders H Berg; Christopher McCoy; James E Kirby
Journal:  Diagn Microbiol Infect Dis       Date:  2017-03-16       Impact factor: 2.803

4.  Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology.

Authors:  Thea Brennan-Krohn; Katherine A Truelson; Kenneth P Smith; James E Kirby
Journal:  J Antimicrob Chemother       Date:  2017-10-01       Impact factor: 5.790

5.  Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.

Authors:  Sylvie Garneau-Tsodikova; Kristin J Labby
Journal:  Medchemcomm       Date:  2015-09-21       Impact factor: 3.597

6.  Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method.

Authors:  Thea Brennan-Krohn; James E Kirby
Journal:  J Vis Exp       Date:  2019-04-18       Impact factor: 1.355

7.  Evaluation of spectinomycin and gentamicin in the treatment of hospitalized patients with resistant urinary tract infections.

Authors:  L K Pickering; H L DuPont; T K Satterwhite
Journal:  Am J Med Sci       Date:  1977 Nov-Dec       Impact factor: 2.378

8.  Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin.

Authors:  Tanja Matt; Chyan Leong Ng; Kathrin Lang; Su-Hua Sha; Rashid Akbergenov; Dmitri Shcherbakov; Martin Meyer; Stefan Duscha; Jing Xie; Srinivas R Dubbaka; Déborah Perez-Fernandez; Andrea Vasella; V Ramakrishnan; Jochen Schacht; Erik C Böttger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-14       Impact factor: 11.205

9.  In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii.

Authors:  Mario Juhas; Emma Widlake; Jeanette Teo; Douglas L Huseby; Jonathan M Tyrrell; Yury S Polikanov; Onur Ercan; Anna Petersson; Sha Cao; Ali F Aboklaish; Anna Rominski; David Crich; Erik C Böttger; Timothy R Walsh; Diarmaid Hughes; Sven N Hobbie
Journal:  J Antimicrob Chemother       Date:  2019-04-01       Impact factor: 5.790

10.  Genomic Analysis of a Pan-Resistant Isolate of Klebsiella pneumoniae, United States 2016.

Authors:  Tom J B de Man; Joseph D Lutgring; David R Lonsway; Karen F Anderson; Julia A Kiehlbauch; Lei Chen; Maroya Spalding Walters; Maria Sjölund-Karlsson; J Kamile Rasheed; Alexander Kallen; Alison Laufer Halpin
Journal:  mBio       Date:  2018-04-03       Impact factor: 7.867
View more
  8 in total

1.  Apralogs: Apramycin 5-O-Glycosides and Ethers with Improved Antibacterial Activity and Ribosomal Selectivity and Reduced Susceptibility to the Aminoacyltranserferase (3)-IV Resistance Determinant.

Authors:  Jonathan C K Quirke; Parasuraman Rajasekaran; Vikram A Sarpe; Amr Sonousi; Ivan Osinnii; Marina Gysin; Klara Haldimann; Qiao-Jun Fang; Dimitri Shcherbakov; Sven N Hobbie; Su-Hua Sha; Jochen Schacht; Andrea Vasella; Erik C Böttger; David Crich
Journal:  J Am Chem Soc       Date:  2019-12-17       Impact factor: 15.419

2.  Predictive Analysis of the Side Chain Conformation of the Higher Carbon Sugars: Application to the Preorganization of the Aminoglycoside Ring 1 Side Chain for Binding to the Bacterial Ribosomal Decoding A Site.

Authors:  Michael G Pirrone; Marina Gysin; Klara Haldimann; Sven N Hobbie; Andrea Vasella; David Crich
Journal:  J Org Chem       Date:  2020-09-23       Impact factor: 4.354

3.  Transcriptomics Reveals How Minocycline-Colistin Synergy Overcomes Antibiotic Resistance in Multidrug-Resistant Klebsiella pneumoniae.

Authors:  Thea Brennan-Krohn; Alexandra Grote; James E Kirby; Ashlee M Earl; Shade Rodriguez
Journal:  Antimicrob Agents Chemother       Date:  2022-01-18       Impact factor: 5.938

4.  Project IDentif.AI: Harnessing Artificial Intelligence to Rapidly Optimize Combination Therapy Development for Infectious Disease Intervention.

Authors:  Aynur Abdulla; Boqian Wang; Feng Qian; Theodore Kee; Agata Blasiak; Yoong Hun Ong; Lissa Hooi; Falgunee Parekh; Rafael Soriano; Gene G Olinger; Jussi Keppo; Chris L Hardesty; Edward K Chow; Dean Ho; Xianting Ding
Journal:  Adv Ther (Weinh)       Date:  2020-04-16

Review 5.  Using Omics Technologies and Systems Biology to Identify Epitope Targets for the Development of Monoclonal Antibodies Against Antibiotic-Resistant Bacteria.

Authors:  Antonio J Martín-Galiano; Michael J McConnell
Journal:  Front Immunol       Date:  2019-12-10       Impact factor: 7.561

6.  Antifungal Combination of Ethyl Acetate Extract of Poincianella pluviosa (DC.) L. P. Queiros Stem Bark With Amphotericin B in Cryptococcus neoformans.

Authors:  Gabriella Maria Andriani; Ana Elisa Belotto Morguette; Laís Fernanda Almeida Spoladori; Patrícia Morais Lopes Pereira; Weslei Roberto Correia Cabral; Bruna Terci Fernandes; Eliandro Reis Tavares; Ricardo Sérgio Almeida; Cesar Armando Contreras Lancheros; Celso Vataru Nakamura; João Carlos Palazzo Mello; Lucy Megumi Yamauchi; Sueli Fumie Yamada-Ogatta
Journal:  Front Microbiol       Date:  2021-06-10       Impact factor: 5.640

7.  Epidemiologic, Phenotypic, and Structural Characterization of Aminoglycoside-Resistance Gene aac(3)-IV.

Authors:  Michel Plattner; Marina Gysin; Klara Haldimann; Katja Becker; Sven N Hobbie
Journal:  Int J Mol Sci       Date:  2020-08-25       Impact factor: 5.923

Review 8.  New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae.

Authors:  Thea Brennan-Krohn; Roman Manetsch; George A O'Doherty; James E Kirby
Journal:  Transl Res       Date:  2020-03-02       Impact factor: 7.012
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.